0.723 2.8 4.1 5.8
 *P* value <0.001 1.000 3.2 6.7 10.0 ###### Clinical characteristics of the study population. -------------------------- ------------------------ ------------------------- ------------------------ Characteristics Favorable Unfavorable *P* Odds ratio Confidence interval *Z* score Gender οΏ½0.932 Female 8 7 11.9 9.7--15.3 (0.8--1.2) (βˆ’1.6--4.0) 0 βˆ’1.1 Age Β 0.731 18--30 12 15 13.1* 5--18.9**  (0.6--1--2.3)*# β€‰β€‰β€Šβ€‰1.4 * *P *<*β€Š*0.05; ***Pβ€Š< 0.01; #*β€―*Pβ€―<β€―0,05;  * *β€…*P,0.1. --------------------------- ------------------------ --------------------------------------------------- The mean score of the QOL in the favorable group was 13.9 ± 3.9, which was significantly higher than in the unfavorable group (9.7 + 2.8, *PΒ *<β€…0.0001). The mean score in the age group of 18--29 was 13 > 13 = 15, which is significantly higher (*PοΏ½* < 0.005). The score of QOL was not significantly different between the age groups of 30--39 and 40--49. The mean scores of QLQ-C30 in the male and female groups were 13.4 and 13.5, respectively, which were significantly higher compared with the female group (*P*οΏ½Β < 0.049). The scores of the total score, physical, psychological, and social function were significantly lower in the female than in male groups (*PΒ <Β *0,049), and the scores of all domains were significantly different among the age subgroups (*P<*0 5).   QL-C40 Mean Score Total score Physical function Psychological function Social function Female group 14.2 4  9.1 8  11.8 6 19.1     7.3 10 17.4  7 β€…3.3  2 β€Š2.1 2.1 3.1 4.4 Male group 13β€Š3β€Š9  9.8   11.3^#^ β€ˆ6.8 7.8^*^ 16.5    3.1^$^   2.3 2.4 2.2 2.6 2.7 3.3 Total   7.6 12 ‍8.1 12.4^^^ 20.3 12.3 11.6^^Β£^ 13 β€―5.6 8.1 6.4 5.7 6.3 7.3 9.9 30--49 group 15.6 β€Œ8.3 10.6 ^#^^^^ ^ 15  6.1 8.3 8.2 9.3 6.2 7.7 8.7 50--59 group 14β€Š4β€Œβ€Š7  9  7.2^\^^^ 12.8 9.2 8.4 7.9 7.2 6.9 6.5 60--69 group 12β€Š6β€Œ9 β€Šβ€Š8.8 8.8 10.1 11.1 10.7 11.3 13.3 14.4 15.4 17.3 19.2 70--79 group 11β€Š1β€Œ4 β€Œβ€Œ7.1 7.1 9.1 13.2 12.2 14.5 17.7 19.3 21.5 23.9 24.9 26.2 27.6 80--89 group 9β€Š5β€Œ6 ‏7.8 6.8 11.4 14.1 15.1 17.6 19.4 21.8 23.2 25.4 26.1 28.1 29.1 30.2 30.